Optimizing Metformin Use in Polycystic Ovary Syndrome

NCT07120815 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

184

Enrollment

OTHER

Sponsor class

Conditions

Polycystic Ovary Syndrome (PCOS)

Interventions

DRUG: Metformin 1500 mg daily
DRUG: Metformin 2250 mg daily

Sponsor

Helsinki University Central Hospital

Collaborators

[object Object]
[object Object]
[object Object]